NCT04876651
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04876651
Title The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only
Recruitment Terminated
Gender male
Phase Phase III
Variant Requirements Yes
Sponsors Telix Pharmaceuticals (Innovations) Pty Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries NZL | AUS

Facility Status City State Zip Country Details
Westmead Hospital Westmead New South Wales 2145 Australia Details
Princess Alexandra Hospital Woolloongabba Queensland 4102 Australia Details
Monash Health Clayton Victoria 3168 Australia Details
Austin Health Melbourne Victoria 3083 Australia Details
'GenesisCare Murdoch' Murdoch Western Australia 6150 Australia Details
Auckland City Hospital Auckland 1023 New Zealand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field